Indication
Preserved Ejection Fraction
2 clinical trials
2 products
Clinical trial
Characterization of Heart Failure With Preserved Ejection FractionStatus: Recruiting, Estimated PCD: 2028-12-01
Product
biomarkerClinical trial
The Efficacy of Enavogliflozin on Exercise Performance and Diastolic Function in Heart Failure With Preserved Ejection Fraction: A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
SGLT2 inhibitor